Efficacy of angiotensin receptor blockers for nocturnal blood pressure reduction: a systematic review and meta-analysis

被引:1
|
作者
Liu, Jing [1 ]
Chen, Wei [1 ]
Shao, Shihuan [1 ]
Chen, Yuanyuan [1 ]
Wang, Hongyi [1 ]
Xi, Yang [1 ]
Wang, Luyan [1 ]
机构
[1] Peking Univ Peoples Hosp, Dept Hypertens, 11 Xizhimen South St, Beijing 100044, Peoples R China
关键词
Angiotensin II AT1 receptor antagonists (ARBs); nocturnal blood pressure; hypertension; meta-analysis; MODERATE ESSENTIAL-HYPERTENSION; SERUM URIC-ACID; DOUBLE-BLIND; ANTIHYPERTENSIVE EFFICACY; CANDESARTAN CILEXETIL; OLMESARTAN MEDOXOMIL; KOREAN PATIENTS; OPEN-LABEL; 50; MG; LOSARTAN;
D O I
10.1080/07853890.2024.2362880
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundNocturnal blood pressure (BP) is correlated with an increased risk of cardiovascular events and is an important predictor of cardiovascular death in hypertensive patients.ObjectiveNocturnal BP control is of great importance for cardiovascular risk reduction. This systematic review and meta-analysis aimed to explore the efficacy of angiotensin receptor blockers (ARBs) for nocturnal BP reduction in patients with mild to moderate hypertension.MethodsPICOS design structure was used to formulate the data extraction. All statistical calculations and analyses were performed with R.ResultsSeventy-seven studies with 13,314 participants were included. The overall analysis indicated that nocturnal BP drop varied considerably among different ARBs. Allisartan (13.04 [95% CI (-18.41, -7.68)] mmHg), olmesartan (11.67 [95% CI (-14.12, -9.21)] mmHg), telmisartan (11.11 [95% CI (-12.12, -10.11)] mmHg) were associated with greater reduction in nocturnal systolic BP. In the aspect of the nocturnal-diurnal BP drop ratio, only allisartan was greater than 1. While, the variation tendency of last 4-6 h ambulatory BP was basically consistent with nocturnal BP. Additionally, allisartan showed improvement effect in the proportion of patients with dipping BP pattern.ConclusionsThis study demonstrates that for patients with mild to moderate hypertension, allisartan, olmesartan and telmisartan have more advantages in nocturnal BP reduction among the ARBs, while allisartan can reduce nighttime BP more than daytime BP and improve the dipping pattern. This meta-analysis explores the efficacy of Angiotensin II AT1 receptor antagonists (ARBs) on nocturnal blood pressure (BP) reduction in mild to moderate hypertension.The results demonstrate that for patients with mild to moderate hypertension, allisartan, olmesartan and telmisartan have more advantages in nocturnal BP reduction among the ARBs.Allisartan can reduce nighttime BP more effectively than daytime BP, which also improve the dipping pattern.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Systematic Review with Network Meta-Analysis: Comparative Efficacy and Safety of Combination Therapy with Angiotensin II Receptor Blockers and Amlodipine in Asian Hypertensive Patients
    Lee, Dae Wook
    Jung, Mira
    Wang, Hye Won
    Khan, Zainah
    Pinton, Philippe
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2019, 2019
  • [42] SYSTEMATIC REVIEW WITH NETWORK META-ANALYSIS: COMPARATIVE EFFICACY AND SAFETY OF FIXED DOSE COMBINATIONS OF ANGIOTENSIN II RECEPTOR BLOCKERS AND AMLODIPINE IN ASIAN HYPERTENSION
    Lee, D. W.
    Jung, M.
    Wang, H. Won
    Khan, Z.
    Pinton, P.
    JOURNAL OF HYPERTENSION, 2019, 37 : E173 - E173
  • [43] Stress reduction programs in patients with elevated blood pressure: A systematic review and meta-analysis
    Rainforth, Maxwell V.
    Schneider, Robert H.
    Nidich, Sanford I.
    Gaylord-King, Carolyn
    Salerno, John W.
    Anderson, James W.
    CURRENT HYPERTENSION REPORTS, 2007, 9 (06) : 520 - 528
  • [44] Blood pressure lowering effect of calcium channel blockers on perioperative hypertension A systematic review and meta-analysis
    Lin, Yu
    Ma, Lina
    MEDICINE, 2018, 97 (48)
  • [45] Does Nocturnal Blood Pressure Matter in Retinal Small Vessels? A Systematic Review and Meta-Analysis of the Literature
    Antza, Christina
    Palaska, Smaro
    Anyfanti, Panagiota
    Triantis, Dimitris
    Fyntrilakis, Stavros
    Ziyasener, Yusuf
    Kotsis, Vasilios
    CURRENT HYPERTENSION REPORTS, 2025, 27 (01)
  • [46] Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis
    Georgianos, Panagiotis, I
    Tziatzios, Georgios
    Roumeliotis, Stefanos
    Vaios, Vasilios
    Sgourogoulou, Vasiliki
    Tsalikakis, Dimitrios G.
    Liakopoulos, Vassilios
    Agarwal, Rajiv
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (01) : 203 - 211
  • [47] Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis
    Lo, Kevin Bryan
    Bhargav, Ruchika
    Salacup, Grace
    Pelayo, Jerald
    Albano, Jeri
    McCullough, Peter A.
    Rangaswami, Janani
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (12) : 919 - 930
  • [48] ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PERITONEAL DIALYSIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Akbari, Ayub
    Knoll, Greg
    Ferguson, Dean
    McCormick, Brendan
    Davis, Alexandra
    Biyani, Mohan
    PERITONEAL DIALYSIS INTERNATIONAL, 2009, 29 (05): : 554 - 561
  • [49] Impact of Angiotensin Receptor Blockers (ARB) versus Other Antihypertensive Medication on Blood Pressure in Patients on Dialysis: A Meta-Analysis
    Devi, D. S. Karthika
    Mary, J. Jenifer Florence
    Mohan, Reenaa
    Gavlasova, Dominika
    Kalaiselvan, G.
    Kathiravan, E.
    Foppiani, Jose A.
    Saravanan, V.
    Devi, M. Archana
    Lin, Samuel J.
    INDIAN JOURNAL OF NEPHROLOGY, 2024, 34 (05) : 431 - 441
  • [50] Efficacy and Safety of Eculizumab for Paroxysmal Nocturnal Hemoglobinuria: A Systematic Review and Meta-Analysis
    Zhou, Shuang
    Dong, Xiu
    Chen, Chaoyang
    Ma, Lingyun
    Wu, Ye
    Zhou, Ying
    Cui, Yimin
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (06) : 203 - 210